| 发明名称 |
NULL IGF FOR THE TREATMENT OF CANCER |
| 摘要 |
New methods for the treatment of cancer are provided. Null IGF(IGF variants with reduced receptor binding) is administered to subjects having cancer, thereby alleviating the symptoms of the cancer.</SDO AB>
|
| 申请公布号 |
CA2345353(C) |
申请公布日期 |
2009.07.07 |
| 申请号 |
CA19992345353 |
申请日期 |
1999.09.29 |
| 申请人 |
CELTRIX PHARMACEUTICALS, INC. |
发明人 |
MASCARENHAS, DESMOND |
| 分类号 |
A61K38/30;C07D233/42;A61K31/4164;A61K31/505;A61K31/7068;A61K38/27;A61P35/00;C07D239/56 |
主分类号 |
A61K38/30 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
